References

Ahmad S, O'Donnell D, Payza K, Ducharme J, Menard D, Brown W et al. (1998). Cloning and evaluation of the role of rat GALR-2, a novel subtype of galanin receptor, in the control of pain perception. Ann N YAcad Sci, 863, 108-19. Amiranoff B, Lorinet AM, and LaburtheM (1989). Galanin receptor in the rat pancreatic beta cell line

Rin m 5F. Molecular characterization by chemical cross-linking. J Biol Chem 264, 20 714-7. Arvidsson U, Ulfhake B, Cullheim S, Bergstrand A, Theodorson E, and Hökfelt T (1991). Distribution of 125I-galanin binding sites, immunoreactive galanin, and its coexistence with 5-hydroxytryptamine in the cat spinal cord: biochemical, histochemical, and experimental studies at the light and electron microscopic level. J Comp Neurol 308, 115-38.

Bartfai T, Hökfelt T, and Langel Ü (1993). Galanin—a neuroendocrine peptide. Crit Rev Neurobiol 7, 229-74.

Ben-Ari Y (1990). Modulation of ATP sensitive K+ channels: a novel strategy to reduce the deleterious effects of anoxia. Adv Exp Med Biol 268, 481-9.

Berthold M and Bartfai T (1997). Modes of peptide binding in G protein-coupled receptors. Neurochem Res 22, 1023-31.

Berthold M, Kahl U, Jureus A, Kask K, Nordvall G, Langel, Ü, and Bartfai T (1997). Mutagenesis and ligand modification studies on galanin binding to its GTP-binding-protein-coupled receptor GalR1. Eur J Biochem 249, 601-6.

Billecocq A, Hedlund PB, Bolanos-Jimenez F, and Fillion G (1994). Characterization of galanin and 5-HT1A receptor coupling to adenylyl cyclase in discrete regions of the rat brain. Eur J Pharmacol 269, 209-17.

Blakeman KH, Holmberg K, Hao JX, Xu XJ, Kahl U, Lendahl U et al. (2001). Mice over-expressing galanin have elevated heat nociceptive threshold. Neuroreport 12, 423-5.

Bloomquist BT, Beauchamp MR, Zhelnin L, Brown SE, Gore-Willse AR, Gregor P, and Cornfield LJ

(1998). Cloning and expression of the human galanin receptor GalR2. Biochem BiophysRes Commun 243, 474-9.

Borowsky B, Walker MW, Huang LY, Jones KA, Smith KE, Bard J et al (1998). Cloning and characterization of the human galanin GALR2 receptor. Peptides 19, 1771-81.

Branchek T, Smith KE, and Walker MW (1998). Molecular biology and pharmacology of galanin receptors. Ann N YAcad Sci 863, 94-107.

Branchek TA, Smith KE, Gerald C, and Walker MW (2000). Galanin receptor subtypes. Trends Pharmacol Sci 21, 109-17.

Burazin TC and Gundlach AL (1998). Inducible galanin and GalR2 receptor system in motor neuron injury and regeneration. J Neurochem 71, 879-82.

Burgevin MC, Loquet I, Quarteronet D, and Habert-Ortoli E (1995). Cloning, pharmacological characterization, and anatomical distribution of a rat cDNA encoding for a galanin receptor. J Mol Neurosci 6, 33-41.

Chan-Palay V (1988). Neurons with galanin innervate cholinergic cells in the human basal forebrain and galanin and acetylcholine coexist. Brain Res Bull 21, 465-72.

Crawley JN (1996). Minireview. Galanin-acetylcholine interactions: relevance to memory and Alzheimer's disease. Life Sci 58, 2185-99.

Crawley, JN (1999). The role of galanin in feeding behavior. Neuropeptides 33, 369-75.

Crawley JN and Wenk GL (1989). Co-existence of galanin and acetylcholine: is galanin involved in memory processes and dementia? Trends Neurosci 12, 278-82.

Fathi Z, Battaglino PM, Iben LG, Li H, Baker E, Zhang D etal. (1998a). Molecular characterization, pharmacological properties and chromosomal localization of the human GALR2 galanin receptor. Brain Res Mol Brain Res 58, 156-69.

Fathi Z, Cunningham AM, Iben LG, Battaglino PB, Ward SA, Nichol KA etal. (1997). Cloning, pharmacological characterization and distribution of a novel galanin receptor. Brain Res Mol Brain Res 51,49-59.

Fathi Z, Cunningham AM, Iben LG, Battaglino PB, Ward SA, Nichol KA etal. (1998b). Cloning, pharmacological characterization and distribution of a novel galanin receptor. Brain Res Mol Brain Res 53, 348.

Faure-Virelizier C, CroixD, Bouret S, Prevot V, Reig S, Beauvillain JC, and Mitchell V (1998). Effects of estrous cyclicity on the expression ofthe galanin receptor Gal-R1 in the rat preoptic area: acomparison with the male. Endocrinology 139, 4127-39.

Fisone G, Berthold M, Bedecs K, Unden A, Bartfai T, Bertorelli R et al. (1989). N-terminal galanin-(1-16) fragment is an agonist at the hippocampal galanin receptor. Proc Natl Acad Sci USA 86, 9588-91.

Fisone G, Wu CF, Consolo S, Nordstrom O, Brynne N, Bartfai T et al. (1987). Galanin inhibits acetylcholine release in the ventral hippocampus of the rat: histochemical, autoradiographic, in vivo, and in vitro studies. Proc Natl Acad Sci USA 84, 7339-43.

Gustafson EL, Smith KE, Durkin MM, Gerald C, and Branchek TA (1996). Distribution of a rat galanin receptor mRNA in rat brain. Neuroreport 7, 953-7.

Habert-Ortoli E, Amiranoff B, Loquet I, Laburthe M, and Mayaux JF (1994). Molecular cloning of a functional human galanin receptor. Proc Natl Acad Sci USA 91, 9780-3.

Howard AD, Tan C, Shiao LL, Palyha OC, McKee KK, Weinberg DH etal. (1997). Molecular cloning and characterization of a new receptor for galanin. FEBS Lett405, 285-90.

Iismaa TP, Fathi Z, Hort YJ, Iben LG, Dutton JL, Baker E et al (1998). Structural organization and chromosomal localization of three human galanin receptor genes. Ann N Y Acad Sci 863, 56-63.

Jacoby AS, Webb GC, Liu ML, Kofler B, Hort YJ, Fathi Z etal. (1997). Structural organization of the mouse and human GALR1 galanin receptor genes (Galnr and GALNR) and chromosomal localization of the mouse gene. Genomics 45, 496-508.

Kask K, Berthold M, Kahl U, Nordvall G, and Bartfai T (1996). Delineation of the peptide binding site of the human galanin receptor. Embo J15, 236-44.

Kohler C and Chan-Palay V (1990). Galanin receptors in the post-mortem human brain. Regional distribution of 125I-galanin binding sites using the method of in vitro receptor autoradiography. NeurosciLett 120, 179-82.

Kohler C, Persson A, Melander T, Theodorsson E, Sedvall G, and Hokfelt T (1989). Distribution of galanin-binding sites in the monkey and human telencephalon: preliminary observations. Exp Brain Res 75, 375-80.

Kokaia M, Holmberg K, Nanobashvili A, Xu ZQ, Kokaia Z, Lendahl U et al. (2001). Suppressed kindling epileptogenesis in mice with ectopic overexpression of galanin. Proc Natl Acad Sci USA 98, 14 006-11.

Kolakowski LF, Jr, O'Neill GP, Howard AD, Broussard SR, Sullivan KA, Feighner SD etal. (1998). Molecular characterization and expression of cloned human galanin receptors GALR2 and GALR3. JNeurochem 71, 2239-51.

Land T, Langel U, Low M, Berthold M, Unden A, and Bartfai T (1991). Linear and cyclic N-terminal galanin fragments and analogs as ligands at the hypothalamic galanin receptor. Int J Pept Protein Res 38, 267-72.

Landry M, Aman K, and Hokfelt T (1998). Galanin-R1 receptor in anterior and mid-hypothalamus: distribution and regulation. JComp Neurol 399, 321-40.

Liu HX, Brumovsky P, Schmidt R, Brown W, Payza K, HodzicL etal. (2001). Receptor subtype-specific pronociceptive and analgesic actions of galanin in the spinal cord: selective actions via GalR1 and GalR2 receptors. Proc Natl Acad Sci USA 98, 9960-4.

Lorimer DD and Benya RV (1996). Cloning and quantification of galanin-1 receptor expression by mucosal cells lining the human gastrointestinal tract. Biochem Biophys Res Commun 222, 379-85.

Lorimer DD, Matkowskj K, and Benya RV (1997). Cloning, chromosomal location, and transcriptional regulation of the human galanin-1 receptor gene (GALN1R). Biochem Biophys Res Commun 241, 558-64.

Mazarati A, Langel U, and Bartfai T (2001). Galanin: an endogenous anticonvulsant? Neuroscientist7, 506-17.

Mazarati AM, Halaszi E, and Telegdy G (1992). Anticonvulsive effects of galanin administered into the central nervous system upon the picrotoxin-kindled seizure syndrome in rats. Brain Res 589, 164-6.

Mazarati AM, Hohmann JG, Bacon A, Liu H, Sankar R, Steiner RA et al. (2000). Modulation of hippocampal excitability and seizures by galanin. JNeurosci 20, 6276-81.

Mazarati AM, Liu H, Soomets U, Sankar, R, Shin D, Katsumori H etal. (1998). Galanin modulation of seizures and seizure modulation of hippocampal galanin in animal models of status epilepticus. JNeurosci 18, 10 070-7.

Melander T, Hokfelt T, and Rokaeus A (1986a). Distribution of galaninlike immunoreactivity in the rat central nervous system. J Comp Neurol 248, 475-517.

Melander T, Hokfelt T, Rokaeus A, Cuello AC, Oertel WH, Verhofstad A, and Goldstein M (1986b). Coexistence of galanin-like immunoreactivity with catecholamines, 5-hydroxytryptamine, GABA and neuropeptides in the rat CNS. JNeurosci 6, 3640-54.

Melander T and Staines WA (1986). A galanin-like peptide coexists in putative cholinergic somata of the septum-basal forebrain complex and in acetylcholinesterase-containing fibers and varicosities within the hippocampus in the owl monkey (Aotus trivirgatus). Neurosci Lett 68, 17-22.

Melander T, Staines WA, Hokfelt T, Rokaeus A, Eckenstein F, Salvaterra PM, and Wainer BH (1985). Galanin-like immunoreactivity in cholinergic neurons of the septum-basal forebrain complex projecting to the hippocampus of the rat. Brain Res 360, 130-8.

Merchenthaler I (1991). The hypophysiotropic galanin system of the rat brain. Neuroscience 44,643-54.

Mufson EJ, Deecher DC, Basile M, Izenwasse S, and Mash DC (2000). Galanin receptor plasticity within the nucleus basalis in early and late Alzheimer's disease: an in vitro autoradiographic analysis. Neuropharmacology 39, 1404-12.

Mufson EJ, Kahl U, Bowser R, Mash DC, Kordower JH, and Deecher DC (1998). Galanin expression within the basal forebrain in Alzheimer's disease. Comments on therapeutic potential. Ann N YAcad Sci 863,291-304.

Nicholl J, Kofler B, Sutherland GR, Shine J, and Iismaa TP (1995). Assignment of the gene encoding human galanin receptor (GALNR) to 18q23 by in situ hybridization. Genomics 30, 629-30.

O'Donnell D, Ahmad S, Wahlestedt C, and Walker P (1999). Expression of the novel galanin receptor subtype GALR2 in the adult rat CNS: distinct distribution from GALR1. J Comp Neurol 409, 469-81.

Ohman A, Lycksell PO, Andell, S, Langel U, Bartfai T, and Graslund A (1995). Solvent stabilized solution structures of galanin and galanin analogs, studied by circular dichroism spectroscopy. Biochim BiophysActa 1236, 259-65.

Ohman A, Lycksell PO, Jureus A, Langel, U, Bartfai T, and Graslund A (1998). NMR study of the conformation and localization of porcine galanin in SDS micelles. Comparison with an inactive analog and a galanin receptor antagonist. Biochemistry 37, 9169-78.

Ohtaki T, Kumano S, Ishibashi Y, Ogi K, Matsui H, Harada M etal. (1999). Isolation and cDNA cloning of a novel galanin-like peptide (GALP) from porcine hypothalamus. J Biol Chem 274, 37041-5.

PangL, Hashemi T, LeeHJ, MaguireM, GrazianoMP, BayneM etal. (1998). The mouse GalR2 galanin receptor: genomic organization, cDNA cloning, and functional characterization. J Neurochem 71, 2252-9.

Parker EM, Izzarelli DG, Nowak HP, Mahle CD, Iben LG, Wang J, and Goldstein ME (1995). Cloning and characterization of the rat GALR1 galanin receptor from Rin14B insulinoma cells. Brain Res Mol Brain Res 34, 179-89.

Puar MS, Barrabee E, Hallade M, and Patel M (2000). Sch 420789: a novel fungal metabolite with phospholipase D inhibitory activity J Antibiot (Tokyo) 53, 837-8.

Rossowski WJ, Rossowski TM, Zacharia S, Ertan A, and Coy DH (1990). Galanin binding sites in rat gastric and jejunal smooth muscle membrane preparations. Peptides 11, 333-8.

Saar K, Mazarati AM, Mahlapuu R, Hallnemo G, Soomets U, Kilk K, Hellberg S, Pooga M, Tolf B-R, Shi TS, Hökfelt T, Wasterlain C, Bartfai T, and Langel U (2002). Anticonvulsant activity of a nonpeptide galanin receptor agonist. Proc Natl Acad Sci USA 99, 7136-41.

Scott MK, Ross TM, Lee DH, Wang HY, Shank RP, Wild KD etal. (2000). 2,3-Dihydro-dithiin and-dithiepine-1,1,4,4-tetroxides: small molecule non-peptide antagonists ofthe human galanin hGAL-1 receptor. BioorgMed Chem 8, 1383-91.

Servin AL, Amiranoff B, Rouyer-Fessard C, Tatemoto K, and Laburthe M (1987). Identification and molecular characterization of galanin receptor sites in rat brain. Biochem Biophys Res Commun 144, 298-306.

Skofitsch G and Jacobowitz DM (1985). Galanin-like immunoreactivity in capsaicin sensitive sensory neurons and ganglia. Brain Res Bull 15, 191-5.

Skofitsch G, Jacobowitz DM, Amann R, and Lembeck F (1989). Galanin and vasopressin coexist in the rat hypothalamo-neurohypophyseal system. Neuroendocrinology 49, 419-27.

Skofitsch G, Sills MA, and Jacobowitz DM (1986). Autoradiographic distribution of 125I-galanin binding sites in the rat central nervous system. Peptides 7, 1029-42.

Smith KE, Forray C, Walker MW, Jones KA, Tamm JA, Bard J et al. (1997). Expression cloning of a rat hypothalamic galanin receptor coupled to phosphoinositide turnover. J Biol Chem 272, 24612-6.

Smith KE, Walker MW, Artymyshyn R, Bard J, Borowsky B, Tamm JA etal. (1998). Cloned human and rat galanin GALR3 receptors. Pharmacology and activation of G-protein inwardly rectifying K+ channels. J Biol Chem 273, 23 321-6.

Steiner RA, Hohmann JG, Holmes A, Wrenn CC, Cadd G, Jureus A etal. (2001). Galanin transgenic mice display cognitive and neurochemical deficits characteristic of Alzheimer's disease. Proc Natl Acad Sci USA 98,4184-9.

StenShi TJ, Zhang X, Holmberg K, XuZQ andHokfelt T (1997). Expression and regulation ofgalanin-R2 receptors in rat primary sensory neurons: effect of axotomy and inflammation. Neurosci Lett 237, 57-60.

Sullivan KA, Shiao LL and Cascieri MA (1997). Pharmacological characterization and tissue distribution of the human and rat GALR1 receptors. Biochem Biophys Res Commun 233, 823-8.

Tatemoto K, Rokaeus A, Jornvall H, McDonald TJ, and Mutt V (1983). Galanin—a novel biologically active peptide from porcine intestine. FEBS Lett 164, 124-8.

Wang HY, Wild KD, Shank RP, and Lee DH (1999). Galanin inhibits acetylcholine release from rat cerebral cortex via a pertussis toxin-sensitive G(i)protein. Neuropeptides 33, 197-205.

Wang S, Hashemi T, Fried S, Clemmons AL, and Hawes BE (1998). Differential intracellular signaling ofthe GalR1 and GalR2 galanin receptor subtypes. Biochemistry 37, 6711-7.

Wang S, Hashemi T, He C, Strader C, and Bayne M (1997a). Molecular cloning and pharmacological characterization of a new galanin receptor subtype. Mol Pharmacol 52, 337-43.

Wang S, He C, Hashemi T, and Bayne M (1997b). Cloning and expressional characterization of a novel galanin receptor. Identification of different pharmacophores within galanin for the three galanin receptor subtypes. J Biol Chem 272, 31 949-52.

Wang S, He C, Maguire MT, Clemmons AL, Burrier RE, GuzziMF etal. (1997c). Genomic organization and functional characterization ofthe mouse GalR1 galanin receptor. FEBS Lett411, 225-30.

Waters SM, and Krause JE (2000). Distribution of galanin-1, -2 and -3 receptor messenger RNAs in central and peripheral rat tissues. Neuroscience 95, 265-71.

Wiesenfeld-Hallin Z, Bartfai T, and Hokfelt T (1992). Galanin in sensory neurons in the spinal cord. Front Neuroendocrinol 13, 319-43.

Wittau N, Grosse R, Kalkbrenner F, Gohla A, Schultz G, and Gudermann T (2000). The galanin receptor type 2 initiates multiple signaling pathways in small cell lung cancer cells by coupling to G(q), G(i) and G(12) proteins. Oncogene 19, 4199-209.

WynickD, Small CJ, Bloom SR, and PachnisV (1998). Targeted disruption ofthe murine galanin gene. Ann N Y Acad Sci 863, 22-47.

Wynick D, Smith DM, Ghatei M, Akinsanya K, Bhogal R, Purkiss P etal. (1993). Characterization of a high-affinity galanin receptor in the rat anterior pituitary: absence of biological effect and reduced membrane binding of the antagonist M15 differentiate it from the brain/gut receptor. Proc Natl Acad Sci USA 90, 4231-5.

Xu Z. Q, Ma X, Soomets U, Langel U, and Hokfelt T (1999). Electrophysiological evidence for a hyperpolarizing, galanin (1-15)-selective receptor on hippocampal CA3 pyramidal neurons. Proc Natl Acad Sci USA 96, 14 583-7.

0 0

Post a comment